Shixin Liu is pioneering new ways of studying the tiny proteins that copy and transcribe genetic code.

The findings may lead to new therapeutic interventions for certain types of neurodegeneration and cancers.

By editing blood stem cells, researchers show that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins—opening the door to potential single-shot treatments for diseases ranging from HIV to cancer.

Researchers devised a platform for mapping the regulatory nodes where genetic variations converge to drive changes in cell behavior.

Three years in, the Stavros Niarchos Foundation Institute for Global Infectious Disease Research has matured into a working pipeline connecting basic science and emerging therapies.

Researchers created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.

The Rockefeller teams will map immune cell interactions, engineer cells as drug delivery systems, and activate immune responses in hard-to-treat cancers.

Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential applications of her insights could be much broader.

The Rockefeller University Biotech Club is offering a series of talks, bringing in startup founders and industry experts to share their experience of turning lab discoveries into companies.

Researchers used a combination of wet lab research and deep machine learning to pinpoint distinct genetic sequences, work that could inform therapeutic strategies for chronic inflammation.

Long thought to serve as cellular scaffolding, microtubules also reshape the proteins that bind to them—guiding enzyme activity to prevent genetic errors linked to cancer.

Researchers find that ants continually update their sense of nestmate identity and tolerance for outsiders, a discovery that opens the door to studying the neural circuits behind social recognition.

Researchers laid the groundwork for tools that could one day make high-throughput, comprehensive single-cell protein analysis routine.

Grab some popcorn and soda in Carson Family Auditorium.

Researchers were able to shut down certain malignancies by disabling a protein complex that regulates cell differentiation.

Michael Rout has spent decades studying the molecular machinery that controls all traffic in and out of the cell’s nucleus. His research could lead to new treatments for cancer and viral diseases.

Researchers uncovered immune dynamics that may inform future therapies for infection, cancer, and autoimmunity.

The university’s HR department launches a new feature on its centralized platform, which brings together digital tools, leadership training, and in-person learning.

The annual Lewis Thomas Prize for Writing about Science was established by Rockefeller’s trustees in 1993. On March 9, Impey will be honored for his exploration of life’s origins, exoplanets, and humanity’s place in the universe in a ceremony on campus.

In recognition of her outstanding contributions to the understanding and treatment of infections caused by the HIV-1 and SARS CoV-2 viruses, Theodora Hatziioannou has been promoted to research professor.

Gabriella Chua, who did her Ph.D. research in Shixin Liu’s Laboratory of Nanoscale Biophysics, and Andrea Terceros, who did her Ph.D. research in Priya Rajasethupathy’s Skoler Horbach Family Laboratory of Neural Dynamics and Cognition, have been honored with a prize considered to be one of the mo...

Age-related changes in cells are synchronized across organs, suggesting common molecular signals that could be targeted with drugs.

A new cell-free genomics framework isolates the primary impacts of transcription factors and establishes tuberculosis as a model for understanding how genes are regulated.

As New York endured severe snowstorms and its coldest winter in decades, the Plant Operations team kept science moving at Rockefeller's historic campus.

AI holds enormous potential for the biomedical sciences. To get there, scientists are addressing challenges around trustworthiness, training data, and tool design.

Scientists have discovered that a protein once thought to simply help load a factor necessary for the copying of DNA, actually plays a key role in ensuring fast and reliable replication—an insight that could inform research into cancer and other diseases.

A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to this one kind of Chikungunya vaccine, which is no longer available in the U.S.

New work in fruit flies uncovers an electrical trick that allows neurons to compute direction efficiently by juggling multiple signaling mechanisms. These findings could reframe our understanding of how some neurons operate.

Scientists knew that obesity raises the risk of hypertension. Now Paul Cohen's team has uncovered the mechanism—and the enzyme—that explains how fat can stiffen blood vessels and drive blood pressure upward.

New study shows that beige fat suppresses an enzyme that promotes high blood pressure, revealing a new molecular pathway and a potential target for future precision therapies.

What is a scientist who wants to stay in the good graces of both federal funders and private publishers to do?

Tarun Kapoor is tackling a deceptively tricky biochemical challenge: how to speed up the internal machinery of living cells.

New work demonstrates how neural circuits in the brain and muscles of the face work together to respond physically to social cues.

Goulianos, a member of the Rockefeller community since 1971, was a renowned particle physicist who contributed to the discovery of fundamental building blocks of matter. He died Jan 2.

Scientific publishing has a bias against negative results and that hurts science, says Tim Fessenden, editor of Life Science Alliance, a publication of Rockefeller University Press. Here’s how journal editors can help.

Study demonstrates that the Homer1 gene improves focus by reducing "noise" in the prefrontal cortex, with implications for the study of ADHD and other attention disorders.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

Researchers discovered new characteristics of a T cell receptor that’s essential to a variety of cutting-edge T cell immunotherapies.

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Across fields as diverse as evolution, mechanobiology, and antibiotic discovery, here are some of the intriguing discoveries that came out of Rockefeller in 2025.

Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.

Covering topics from osteoarthritis to neurodevelopment, the inaugural symposium of the Marlene Hess Center showcased research that illuminates how biological sex shapes health and disease.

Researchers created this first-of-its kind map by merging 40 ant brains into one.

Elaine Fuchs has spent decades uncovering why our bodies are so good at regenerating skin—and how we might harness that understanding to combat illness, hair loss, and possibly the aging process itself.

A new study reveals that nuclear pore complexes—tiny gateways in a cell’s nuclear membrane—are governed by dynamic action.

Replicative aging of human cells, the result of telomere shortening, is slower at physiological oxygen than at atmospheric oxygen, a difference now shown to be due to low oxygen impairing the ATM kinase response to withered telomeres.

A first-of-its-kind platform reveals how the molecular machine that turns DNA into RNA controls the speed of transcription.

Neuroscientists have long posited that memory functions like an on/off switch—either your brain remembers something or it doesn’t. Priya Rajasethupathy’s team discovered why the truth is more complicated.

New research reveals a cascade of molecular timers unfolding across the hippocampus, thalamus, and cortex determine whether short-term impressions consolidate into long-term memory, with implications for memory-related diseases.

Scientists used light-inducible gene expression to demonstrate that formation of the body axes in human embryo models requires an interplay between chemical cues and mechanical forces.

When under cellular stress, breast cancer cells turn on genes that promote tumor growth and stress resistance.

Birsoy has been promoted to professor with tenure and Cao has been promoted to associate professor. In addition, Birsoy has been named the Joseph L. Goldstein Professor.

According to the 2025 CWTS Leiden Ranking Open edition of over 2,800 universities from 120 countries, Rockefeller has the highest percentage of most frequently cited scientific publications.

Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.

The discovery could greatly improve patient experience and address supply shortages.

A newly identified molecular pathway shifts microglia into a protective state, and may lead to Alzheimer's therapies that can reprogram the brain’s own immune defenses.

The global effort, led by Rockefeller University, just made the most dangerous animal in the world a lot easier to study—and perhaps defeat one day.

Using AI and other cutting-edge techniques, researchers have captured the first near-continuous "molecular movie" of ribosome formation—revealing, frame by frame, how cells build the protein factories that make life possible.

Researchers have discovered the first evidence of what happens when a female mosquito chooses to mate for the one and only time in her life.
View
View